Clinical Trials Browser

Withdrawn × Classical hematology × 90 days × Clear all

NCT06284460 2026-02-13

Phase I/II Study of a Combination of Decitabine and Cedazuridine (ASTX727) and ASTX029, an ERK Inhibitor, for Patients With RAS Pathway Mutant Myelodysplastic Syndromes and Myelodysplastic/Myeloproliferative Neoplasms

Phase 1/2 Withdrawn

Classical hematologyMyeloid

Anemia, Refractory, with Excess of Blasts, Myeloproliferative Disorders

NCT06098755 2026-02-04

The Sequestration of Holistic Stress Management Techniques for Adults

Phase NA Withdrawn

Classical hematologyHead & NeckOther

Brain Injuries, Traumatic, Occupational Stress, Anemia, Anemia, Sickle Cell, Anxiety Disorders, Arthritis, Arthritis, Rheumatoid, Depression, Escape Reaction, Fatigue, Flatfoot, Hemorrhoids, Hypertension, Hyperthyroidism, Immunologic Deficiency Syndromes, Erectile Dysfunction, Leiomyoma, Lordosis, Masturbation, Migraine Disorders, Priapism, Sickle Cell Trait, Stress Disorders, Post-Traumatic, Sexual Dysfunctions, Psychological, Migraine with Aura